These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 16900573)

  • 21. Strength of evidence of non-inferiority trials-The adjustment of the type I error rate in non-inferiority trials with the synthesis method.
    Kang SH; Tsong Y
    Stat Med; 2010 Jun; 29(14):1477-87. PubMed ID: 20535762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A ratio test in active control non-inferiority trials with a time-to-event endpoint.
    Wang YC; Chen G; Chi GY
    J Biopharm Stat; 2006; 16(2):151-64. PubMed ID: 16584064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blinded sample size reassessment in non-inferiority and equivalence trials.
    Friede T; Kieser M
    Stat Med; 2003 Mar; 22(6):995-1007. PubMed ID: 12627414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and analysis of non-inferiority mortality trials in oncology.
    Rothmann M; Li N; Chen G; Chi GY; Temple R; Tsou HH
    Stat Med; 2003 Jan; 22(2):239-64. PubMed ID: 12520560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Power and sample size computations in simultaneous tests for non-inferiority based on relative margins.
    Dilba G; Bretz F; Hothorn LA; Guiard V
    Stat Med; 2006 Apr; 25(7):1131-47. PubMed ID: 16217842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exact sample-size determination in testing non-inferiority under a simple crossover trial.
    Lui KJ; Chang KC
    Pharm Stat; 2012; 11(2):129-34. PubMed ID: 22232060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of multiple testing procedures for the gold standard non-inferiority trial.
    Röhmel J; Pigeot I
    J Biopharm Stat; 2010 Sep; 20(5):911-26. PubMed ID: 20721781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Many-to-one comparison after sample size reestimation for trials with multiple treatment arms and treatment selection.
    Wang J
    J Biopharm Stat; 2010 Sep; 20(5):927-40. PubMed ID: 20721782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal sample allocation in clinical trials designed to investigate relative risks.
    Eastwood BJ
    Stat Med; 1996 Dec; 15(23):2523-38. PubMed ID: 8961461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and analysis of non-inferiority mortality trials in oncology.
    Carroll K; Milsted B; Lewis JA
    Stat Med; 2004 Sep; 23(17):2771-4; author reply 2774-8. PubMed ID: 15316946
    [No Abstract]   [Full Text] [Related]  

  • 31. On non-inferiority analysis based on delta-method confidence intervals.
    Rothmann MD; Tsou HH
    J Biopharm Stat; 2003 Aug; 13(3):565-83. PubMed ID: 12921402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Choice of delta noninferiority margin and dependency of the noninferiority trials.
    Tsong Y; Zhang J; Levenson M
    J Biopharm Stat; 2007; 17(2):279-88. PubMed ID: 17365224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and semiparametric analysis of non-inferiority trials with active and placebo control for censored time-to-event data.
    Kombrink K; Munk A; Friede T
    Stat Med; 2013 Aug; 32(18):3055-66. PubMed ID: 23508697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A note on the power of Fisher's least significant difference procedure.
    Meier U
    Pharm Stat; 2006; 5(4):253-63. PubMed ID: 17128424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simple procedures for blinded sample size adjustment that do not affect the type I error rate.
    Kieser M; Friede T
    Stat Med; 2003 Dec; 22(23):3571-81. PubMed ID: 14652861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Choice of lambda-margin and dependency of non-inferiority trials.
    Tsong Y; Levenson M; Zhang J; Zhong J
    Stat Med; 2008 Feb; 27(4):520-8. PubMed ID: 17617797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
    Lui KJ; Chang KC
    Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control theory: placebo-controlled drug trials have problems. Active-controlled drug trials are not always the solution.
    Golomb BA
    Am J Bioeth; 2009 Sep; 9(9):67-9. PubMed ID: 19998203
    [No Abstract]   [Full Text] [Related]  

  • 39. Minimization of sample size when comparing two small probabilities in a non-inferiority safety trial.
    de Boo TM; Zielhuis GA
    Stat Med; 2004 Jun; 23(11):1683-99. PubMed ID: 15160402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A unifying approach to non-inferiority, equivalence and superiority tests via multiple decision processes.
    Hirotsu C
    Pharm Stat; 2007; 6(3):193-203. PubMed ID: 17879327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.